speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-02
DOI
10.1038/s41467-022-34141-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
- (2022) J. Joseph Melenhorst et al. NATURE
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
- (2022) Michelle J. Cox et al. LEUKEMIA
- Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
- (2022) Yun Chang et al. Cell Reports
- Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
- (2022) Khloe S. Gordon et al. Nature Biomedical Engineering
- Chimeric Antigen Receptor T Cell Therapy in Oncology - Pipeline at a glance: Analysis of the ClinicalTrials.gov database
- (2021) E. Moreno et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Engineering advanced logic and distributed computing in human CAR immune cells
- (2021) Jang Hwan Cho et al. Nature Communications
- Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
- (2021) Jakrawadee Julamanee et al. MOLECULAR THERAPY
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies
- (2021) Rocío Castellanos-Rueda et al. TRENDS IN BIOTECHNOLOGY
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- 9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
- (2021) Kexin Yan et al. Frontiers in Immunology
- CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
- (2021) Minh Tuyet Ma et al. Frontiers in Immunology
- Donor‐specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients
- (2020) Antoine Sicard et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Inclusion of Dap10 or 4-1BB costimulation domains in the chPD1 receptor enhances anti-tumor efficacy of T cells in murine models of lymphoma and melanoma
- (2020) Hailey Kintz et al. CELLULAR IMMUNOLOGY
- Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
- (2020) Alyssa Sheih et al. Nature Communications
- Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
- (2020) Theodore L. Roth et al. CELL
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- A functional screening strategy for engineering chimeric antigen receptors with reduced on-target, off-tumour activation
- (2020) Raphaël B. Di Roberto et al. MOLECULAR THERAPY
- Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy
- (2020) Diana Cortés-Selva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Toxicities of CD19 CAR-T cell immunotherapy
- (2019) Alexandre V. Hirayama et al. AMERICAN JOURNAL OF HEMATOLOGY
- A safe and potent anti-CD19 CAR T cell therapy
- (2019) Zhitao Ying et al. NATURE MEDICINE
- g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
- (2019) Uku Raudvere et al. NUCLEIC ACIDS RESEARCH
- Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
- (2019) Michel Tenspolde et al. JOURNAL OF AUTOIMMUNITY
- Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
- (2019) Rachel Grosser et al. CANCER CELL
- Fast, sensitive and accurate integration of single-cell data with Harmony
- (2019) Ilya Korsunsky et al. NATURE METHODS
- Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
- (2019) David N. Nguyen et al. NATURE BIOTECHNOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density
- (2018) John R. James Science Signaling
- Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density
- (2018) John R. James Science Signaling
- GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
- (2018) Rosalie M. Sterner et al. BLOOD
- Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform
- (2018) Julian Rydzek et al. MOLECULAR THERAPY
- Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen Receptor
- (2018) Ryosuke Uchibori et al. Molecular Therapy-Oncolytics
- Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
- (2017) Malika Hale et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
- (2017) C A van der Weyden et al. Blood Cancer Journal
- Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
- (2017) Brahma V. Kumar et al. Cell Reports
- Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies
- (2016) Marco Ruella et al. Computational and Structural Biotechnology Journal
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- The Robustness of a Signaling Complex to Domain Rearrangements Facilitates Network Evolution
- (2014) Paloma M. Sato et al. PLOS BIOLOGY
- The role of domain shuffling in the evolution of signaling networks
- (2013) Raphael B. Di Roberto et al. JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION
- Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach
- (2013) Connie P. M. Duong et al. PLoS One
- CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
- (2012) Moa Fransson et al. Journal of Neuroinflammation
- Rapid Diversification of Cell Signaling Phenotypes by Modular Domain Recombination
- (2010) S. G. Peisajovich et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now